Global Thoracic Outlet Syndrome Market Scope and Market Size
The thoracic outlet syndrome market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
On the basis of type, the thoracic outlet syndrome market is segmented into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.
On the basis of treatment, the thoracic outlet syndrome market is segmented into surgery, medications, physical therapy and others. The medication segment is further sub-segmented into non-steroidal anti-inflammatory drugs (NSAID), skeletal muscle relaxants, anticoagulants, and botulinum toxin therapeutics.
On the basis of diagnosis, the thoracic outlet syndrome market is segmented into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, computed tomography (CT) scan, magnetic resonance imaging (MRI), magnetic resonance imaging with angiography (MRA), arteriogram/venogram, and blood tests.
On the basis of dosage, the thoracic outlet syndrome market is segmented into injection, tablets and others.
On the basis of route of administration, the thoracic outlet syndrome market is segmented into oral, parenteral and others.
On the basis of end-users, the thoracic outlet syndrome market is segmented into clinic, hospital and others.
The thoracic outlet syndrome market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.